168 related articles for article (PubMed ID: 35762581)
1. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial.
Uchiyama S; Toyoda K; Okamura S; Omae K; Hoshino H; Kimura K; Kitagawa K; Minematsu K; Yamaguchi T
Int J Stroke; 2023 Apr; 18(4):426-432. PubMed ID: 35762581
[TBL] [Abstract][Full Text] [Related]
2. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
[TBL] [Abstract][Full Text] [Related]
3. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
[TBL] [Abstract][Full Text] [Related]
4. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
6. Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis.
Uchiyama S; Toyoda K; Omae K; Saita R; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T
J Am Heart Assoc; 2021 Oct; 10(20):e022575. PubMed ID: 34622679
[TBL] [Abstract][Full Text] [Related]
7. Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com.
Hoshino H; Toyoda K; Omae K; Takahashi K; Uchiyama S; Kimura K; Yamaguchi K; Minematsu K; Origasa H; Yamaguchi T
J Atheroscler Thromb; 2023 Jun; 30(6):675-683. PubMed ID: 36070920
[TBL] [Abstract][Full Text] [Related]
8. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis.
Toyoda K; Omae K; Hoshino H; Uchiyama S; Kimura K; Miwa K; Minematsu K; Yamaguchi K; Suda Y; Toru S; Kitagawa K; Ihara M; Koga M; Yamaguchi T;
Neurology; 2022 Mar; 98(10):e983-e992. PubMed ID: 35074890
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation.
Liu H; Shao T; Yang T; Li D; Wang H; Cheng Y; Zhang T; Zhang J
J Atheroscler Thromb; 2023 Aug; 30(8):1010-1021. PubMed ID: 36328566
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 1-Year Outcomes of Triple (Aspirin + Clopidogrel + Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin + Clopidogrel + Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial.
Lee CH; Lee JY; Park GM; Lee SW; Kim HS; Choi YJ; Nam CW; Cho JH; Shin WY; Seo JB; Choi SW; Lee JH; Min PK; Her SH; Lee PH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
Am J Cardiol; 2018 Feb; 121(4):423-429. PubMed ID: 29273207
[TBL] [Abstract][Full Text] [Related]
11. Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines.
Shah J; Liu S; Yu W
Stroke Vasc Neurol; 2022 Oct; 7(5):406-414. PubMed ID: 35393359
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
[TBL] [Abstract][Full Text] [Related]
13. Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack.
Huang HY; Chen JH; Chi NF; Chen YC
J Atheroscler Thromb; 2024 Jun; 31(6):904-916. PubMed ID: 38092384
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicenter Registry.
Lee HL; Kim JT; Lee JS; Park MS; Choi KH; Cho KH; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Sun Oh M; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Lee J; Bae HJ
Circ Cardiovasc Qual Outcomes; 2020 Nov; 13(11):e006474. PubMed ID: 33201737
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
[TBL] [Abstract][Full Text] [Related]
16. Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies.
Moustafa B; Testai FD
Curr Neurol Neurosci Rep; 2022 Nov; 22(11):789-802. PubMed ID: 36227497
[TBL] [Abstract][Full Text] [Related]
17. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.
Tang YD; Wang W; Yang M; Zhang K; Chen J; Qiao S; Yan H; Wu Y; Huang X; Xu B; Gao R; Yang Y;
Circulation; 2018 May; 137(21):2231-2245. PubMed ID: 29420189
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
Ding L; Peng B
Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
[TBL] [Abstract][Full Text] [Related]
20. CSPS.com Trial of Adding Cilostazol to Antiplatelet Therapy to Reduce Recurrent Stroke.
Hankey GJ
Stroke; 2020 Feb; 51(2):696-698. PubMed ID: 31826736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
